Evidence map›Paper›PMID 40836086›Full record

ArticleNature2025

Structural basis for the dynamic regulation of mTORC1 by amino acids.

Max L Valenstein, Maximilian Wranik, Pranav V Lalgudi, Karen Y Linde-Garelli, Yuri Choi, Raghu R Chivukula, David M Sabatini, Kacper B Rogala

Abstract read
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Max L Valenstein *Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0001-7616-0148
Maximilian Wranik *Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
Pranav V LalgudiWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID 0000-0003-1653-2338
Karen Y Linde-GarelliDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
Yuri ChoiDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
Raghu R ChivukulaDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA.
David M SabatiniInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic. david.sabatini@iocb.cz.ORCID 0000-0002-1446-7256
Kacper B RogalaDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA. rogala@stanford.edu.ORCID 0000-0001-5997-7770

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI MICHAEL KENNEY · 2007 to 2026
$71.4M
Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Leveraging innovative technologies in basic and clinical cancer researchT32CA009302 · NCI · STANFORD UNIVERSITY · PI LAURA D ATTARDI, Aaron M Newman · 1985 to 2026
$19.1M
Regulation of the mTOR Pathway By NutrientsR01CA103866 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI WEISSMAN, JONATHAN S. · 2004 to 2021
$7.0M
Cell Growth Signaling in Cancer DevelopmentR01CA129105 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI WEISSMAN, JONATHAN S. · 2008 to 2021
$5.9M
TRANSLATIONAL CONTROL BY RAPAMYCIN-SENSITIVE SIGNALINGR01AI047389 · NIAID · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI WEISSMAN, JONATHAN S. · 2000 to 2021
$4.9M
Mechanisms of amino-acid sensing by the GATOR complexR35GM150935 · NIGMS · STANFORD UNIVERSITY · PI Kacper Rogala · 2023 to 2026
$1.4M
Mechanistic insights into lysosomal nutrient efflux in cancerR00CA255926 · NCI · STANFORD UNIVERSITY · PI ROGALA, KACPER · 2022 to 2024
$735k
Elucidating the role of GATOR2 in nutrient sensing by mTORC1F30CA228229 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI VALENSTEIN, MAX · 2018 to 2020
$150k
NCI NIH HHS F30 CA228229NCI NIH HHS P30 CA124435NCI NIH HHS R00 CA255926NCI NIH HHS R01 CA103866NCI NIH HHS R01 CA129105NCI NIH HHS T32 CA009302NIAID NIH HHS R01 AI047389NIGMS NIH HHS R35 GM150935NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

The mechanistic target of rapamycin complex 1 (mTORC1) anchors a conserved signalling pathway that regulates growth in response to nutrient availability

Indexed as

Amino AcidsMechanistic Target of Rapamycin Complex 1Binding SitesCryoelectron MicroscopyHumansIntracellular Signaling Peptides and ProteinsLeucineModels, MolecularNuclear ProteinsProtein BindingSestrinsAmino AcidsCASTOR1 protein, humanIntracellular Signaling Peptides and ProteinsLeucineMechanistic Target of Rapamycin Complex 1Nuclear ProteinsSESN1 protein, humanSESN2 protein, humanSestrins

Identifiers

PMID40836086
PMCPMC12507694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.